127 related articles for article (PubMed ID: 29455169)
1. Positron emission tomography (PET) for prediction of glioma histology: protocol for an individual-level data meta-analysis of test performance.
Trikalinos NA; Nihashi T; Evangelou E; Terasawa T
BMJ Open; 2018 Feb; 8(2):e020187. PubMed ID: 29455169
[TBL] [Abstract][Full Text] [Related]
2. Performance of 18F-FDG, 11C-Methionine, and 18F-FET PET for Glioma Grading: A Meta-analysis.
Katsanos AH; Alexiou GA; Fotopoulos AD; Jabbour P; Kyritsis AP; Sioka C
Clin Nucl Med; 2019 Nov; 44(11):864-869. PubMed ID: 31205150
[TBL] [Abstract][Full Text] [Related]
3. Performance of 18F-FET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysis.
Dunet V; Pomoni A; Hottinger A; Nicod-Lalonde M; Prior JO
Neuro Oncol; 2016 Mar; 18(3):426-34. PubMed ID: 26243791
[TBL] [Abstract][Full Text] [Related]
4. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
[TBL] [Abstract][Full Text] [Related]
5. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
[TBL] [Abstract][Full Text] [Related]
7. [Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas].
Yamaguchi S; Terasaka S; Kobayashi H; Narita T; Hirata K; Shiga S; Usui R; Tanaka S; Kubota K; Murata J; Asaoka K
No Shinkei Geka; 2010 Jul; 38(7):621-8. PubMed ID: 20628188
[TBL] [Abstract][Full Text] [Related]
8. 18F-fluoro-ethyl-tyrosine positron emission tomography for grading and estimation of prognosis in patients with intracranial gliomas.
Gempt J; Bette S; Ryang YM; Buchmann N; Peschke P; Pyka T; Wester HJ; Förster S; Meyer B; Ringel F
Eur J Radiol; 2015 May; 84(5):955-62. PubMed ID: 25748815
[TBL] [Abstract][Full Text] [Related]
9. Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas.
Röhrich M; Huang K; Schrimpf D; Albert NL; Hielscher T; von Deimling A; Schüller U; Dimitrakopoulou-Strauss A; Haberkorn U
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1573-1584. PubMed ID: 29732524
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 3'-deoxy-3'-[18F]fluorothymidine PET and O-(2-[18F]fluoroethyl)-L-tyrosine PET in patients with newly diagnosed glioma.
Jeong SY; Lim SM
Nucl Med Biol; 2012 Oct; 39(7):977-81. PubMed ID: 22483845
[TBL] [Abstract][Full Text] [Related]
11. Combination of MRI and dynamic FET PET for initial glioma grading.
Dunet V; Maeder P; Nicod-Lalonde M; Lhermitte B; Pollo C; Bloch J; Stupp R; Meuli R; Prior JO
Nuklearmedizin; 2014 Aug; 53(4):155-61. PubMed ID: 24737132
[TBL] [Abstract][Full Text] [Related]
12. Role of diffusional kurtosis imaging in grading of brain gliomas: a protocol for systematic review and meta-analysis.
Abdalla G; Sanverdi E; Machado PM; Kwong JSW; Panovska-Griffiths J; Rojas-Garcia A; Yoneoka D; Yousry T; Bisdas S
BMJ Open; 2018 Dec; 8(12):e025123. PubMed ID: 30552282
[TBL] [Abstract][Full Text] [Related]
13. Comparison of effects of 18F-FDG PET-CT and MRI in identifying and grading gliomas.
Song PJ; Lu QY; Li MY; Li X; Shen F
J Biol Regul Homeost Agents; 2016; 30(3):833-838. PubMed ID: 27655507
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive grading of brain tumours using dynamic amino acid PET imaging: does it work for 11C-methionine?
Moulin-Romsée G; D'Hondt E; de Groot T; Goffin J; Sciot R; Mortelmans L; Menten J; Bormans G; Van Laere K
Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2082-7. PubMed ID: 17763978
[TBL] [Abstract][Full Text] [Related]
15. The Sum of Tumour-to-Brain Ratios Improves the Accuracy of Diagnosing Gliomas Using 18F-FET PET.
Malkowski B; Harat M; Zyromska A; Wisniewski T; Harat A; Lopatto R; Furtak J
PLoS One; 2015; 10(10):e0140917. PubMed ID: 26468649
[TBL] [Abstract][Full Text] [Related]
16. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201
[TBL] [Abstract][Full Text] [Related]
17. A meta-analysis comparing 18F-FLT PET with 18F-FDG PET for assessment of brain tumor recurrence.
Li Z; Yu Y; Zhang H; Xu G; Chen L
Nucl Med Commun; 2015 Jul; 36(7):695-701. PubMed ID: 25768337
[TBL] [Abstract][Full Text] [Related]
18. Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma.
Ullrich R; Backes H; Li H; Kracht L; Miletic H; Kesper K; Neumaier B; Heiss WD; Wienhard K; Jacobs AH
Clin Cancer Res; 2008 Apr; 14(7):2049-55. PubMed ID: 18381944
[TBL] [Abstract][Full Text] [Related]
19. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.
Kaschten B; Stevenaert A; Sadzot B; Deprez M; Degueldre C; Del Fiore G; Luxen A; Reznik M
J Nucl Med; 1998 May; 39(5):778-85. PubMed ID: 9591574
[TBL] [Abstract][Full Text] [Related]
20. Oligodendroglial component complicates the prediction of tumour grading with metabolic imaging.
Manabe O; Hattori N; Yamaguchi S; Hirata K; Kobayashi K; Terasaka S; Kobayashi H; Motegi H; Shiga T; Magota K; Oyama-Manabe N; Nishijima K; Kuge Y; Tamaki N
Eur J Nucl Med Mol Imaging; 2015 May; 42(6):896-904. PubMed ID: 25647076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
